Author:
Martin Pamela D.,Argyle David J.
Reference69 articles.
1. World Heath Organization website Skin cancer information. Ultraviolet radiation and the INTERSUN Programme http://www.who.int/uv/faq/skincancer/en/index1.html
2. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision;London;Clin Cancer Res,2009
3. Masitinib is safe and effective for the treatment of canine mast cell tumors;Hahn;J Vet Intern Med,2008
4. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors;Pryer;Clin Cancer Res,2003